Scilex Holding (SCLX) Net Income towards Common Stockholders (QoQ) (2020 - 2026)

Scilex Holding (SCLX) Net Income towards Common Stockholders (QoQ) (2020 - 2026) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn -
10 Scilex Holding 54.30 Mn -95.62 Mn 4.15 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -30.68%
Dec 31, 2025 87.13%
Sep 30, 2025 -198.90%
Jun 30, 2025 -229.99%
Mar 31, 2025 -69.85%
Dec 31, 2024 -249.93%
Sep 30, 2024 88.32%
Jun 30, 2024 -54.17%
Mar 31, 2024 -13.91%
Dec 31, 2023 75.73%
Sep 30, 2023 -230.87%
Jun 30, 2023 13.35%
Mar 31, 2023 -71.96%
Dec 31, 2022 -183.18%
Sep 30, 2022 220.53%
Jun 30, 2022 -95.10%
Mar 31, 2022 74.07%
Dec 31, 2021 -12,425.08%
Sep 30, 2021 -70.28%
Jun 30, 2021 -13.46%